Archegos chaos signals ‘fear of missing out’ rampant on Wall Street, GMO’s Inker tells MarketWatch

Large losses banks potentially face from Archegos Capital Management’s implosion may be one more sign of the fervor playing out in markets marked by excess, according to Ben Inker, head of asset allocation at GMO.